lercanidipine: Clinical Trials

14 trials of lercanidipine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 recruiting, 2 terminated, 2 unknown. 7 Phase 4, 3 Not applicable, 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 47Completed 4, Unknown 2, Terminated 1
Not applicable3Completed 1, Recruiting 1, Terminated 1
Phase 22Completed 2
Phase 31Completed 1

Follow lercanidipine: new trials by email Literature Review of lercanidipine trials Research Report on lercanidipine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Role of Skin Sodium Accumulation in Chronic Kidney Disease
Hydrochlorothiazide, Spironolactone, Lercanidipine - Chronic Kidney Diseases
Not applicableRecruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)602025-01-072025-06-13
Bariatric Surgery and Pharmacokinetics of Lercanidipine
Lercanidipine - Obesity, Morbid
RecruitingNorwegian University of Science and Technology122016-11-022026-07-08
Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)
Lisinopril, Amlodipine - Renal Insufficiency, Chronic, Proteinuria
Phase 4UnknownHospital General Universitario Gregorio Marañon1062015-06-012019-02-22
Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients
Lercanidipine 10mg, Lercanidipine10mg /Valsartan 80mg, Lercanidipine 10mg /Valsartan 160mg - Hypertension
Phase 3CompletedLG Life Sciences4492012-05-012013-08-28
Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for Hypertension
Zanidip, Felodipine sustained-release tablet - Hypertension
Phase 4CompletedLee's Pharmaceutical Limited2812011-12-012014-10-16
Zainidip in Renal Artery Stenosis
stent, Aspirine, Clopidogrel - Hypertension
Phase 4CompletedLee's Pharmaceutical Limited1492011-09-012015-11-03
Antihypertensive Efficacy of Fixed Combination Drug
Lercanidipine/enalapril fixed combination - Hypertension
Phase 4TerminatedMeir Medical Center102011-01-012016-06-28
Intensive Vasodilator Therapy in Patients With Essential Hypertension
Amlodipine, Ramipril, Lercanidipine - Essential Hypertension, High Blood Pressure
Phase 4CompletedAarhus University Hospital482010-12-012012-04-19
Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension
Placebo, Lercanidipine, Enalapril - Essential Hypertension
Phase 2CompletedRECORDATI GROUP10392010-03-012011-04-29
Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension
Lercanidipine + Valsartan, Lercanidipine or Valsartan, Placebo - Essential Hypertension
Phase 2CompletedLG Life Sciences4412009-12-012011-02-18
Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment
Any antihypertensive medication alone or in combination, Ambulatory blood pressure monitoring - Essential Hypertension, Cardiovascular Disease
Phase 4CompletedUniversity of Vigo219832008-09-012018-08-28
Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine
candesartan, lercanidipine - HIV Infections, Hypertension
Phase 4UnknownUniversità degli Studi dell'Insubria302007-09-012007-12-06
Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina Pectoris
Lercanidipine, Valsartan, Nicorandil - Microvascular Angina, Hypertension
Not applicableTerminatedUniversity of Aarhus102007-01-012009-05-06
Testing the Efficacy of Different Dosages of Lercanidipine to Reduce Hypertensive Blood Pressure in Normal Weight and Obese Patients
Lercanidipine - Hypertension
Not applicableCompletedUCB Pharma1802004-05-012008-03-10

Conditions studied

Hypertension (10)  ·  Essential Hypertension (4)  ·  Renal Insufficiency, Chronic (3)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  HIV Infections (1)  ·  Microvascular Angina (1)  ·  Obesity (1)  ·  Obesity, Morbid (1)  ·  Proteinuria (1)  ·  Stroke (1)

Sponsors

LG Life Sciences (2)  ·  Lee's Pharmaceutical Limited (2)  ·  Aarhus University Hospital (1)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Hospital General Universitario Gregorio Marañon (1)  ·  Meir Medical Center (1)  ·  Norwegian University of Science and Technology (1)  ·  RECORDATI GROUP (1)  ·  UCB Pharma (1)  ·  University of Aarhus (1)  ·  University of Vigo (1)  ·  Università degli Studi dell'Insubria (1)

Countries

China (2)  ·  Denmark (2)  ·  South Korea (2)  ·  Spain (2)  ·  France (1)  ·  Israel (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Norway (1)

Top investigators

Ashkan Eftekhari, MD, PhD (1)  ·  Eduardo Podjarny, MD (1)  ·  Giuseppe Mancia, Prof (1)  ·  Kent L Christensen, MD, DrMSc (1)  ·  Maria Angeles Goicoechea, PhD, MD (1)  ·  Morten Engholm Pedersen, MD (1)  ·  Niels Henrik Buus, DMSc (1)  ·  Ole Norling Mathiasen, MD, PhD (1)  ·  Ramon C Hermida, PhD (1)  ·  Rik Olde Engberink, MD, PhD (1)  ·  Won Yong Kim, MD, DrMSc (1)

Results publications

PMID 26164786, PMID 26630216, PMID 27221952, PMID 27779454, PMID 31641769, PMID 38508877